Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.10.29
2019年面向合格投资者公开发行公司债券（第一期）发行结果公告
2019.10.25
2019年面向合格投资者公开发行公司债券（第一期）票面利率公告
2019.10.25
2019年面向合格投资者公开发行公司债券（第一期）发行相关情况的调整公告
2019.10.24
2019年公开发行公司债券（第一期）募集说明书摘要（面向合格投资者）
2019.10.24
2019年公开发行公司债券（第一期）募集说明书（面向合格投资者）
2019.10.24
2019年面向合格投资者公开发行公司债券（第一期）发行公告
2019.10.24
2019年公开发行公司债券（第一期）信用评级报告
2019.10.15
2019年前三季度业绩预告
2019.10.09
关于参股公司新药临床试验进展的提示性公告
2019.09.27
关于“16三里枫香”回售申报情况的公告
第一页
上一页
46
47
48
49
50
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
